00405nam a2200109Ia 4500008004100000245012200041260003500163260000900198300000900207650001300216856006600229170516s9999    xx            000 0 und d  aFormulation Design and Development of Anti-EGFR-BSA-CYP-SLNs In Situ Gel for Nasal Administration Sankha Bhattacharya  bAsian Journal of Pharmaceutics  c2016  a10:4  xPharmacy  uhttp://www.asiapharmaceutics.info/index.php/ajp/issue/view/71